SYQUANT CAPITAL SAS Quant / Systematic

CIK: 0001766392 · Show all filings

Period: Q4 2023 (← Previous) (Next →)

Filing Date: Jan 10, 2024

Total Value ($000): $22 (100.0% shares, 0.0% debt)

Holdings (7)

— MIRATI THERAPEUTICS INC 40.8%

Value ($000) $9 Shares 153,920 Est. Cost $0.06 Unrealized —

— LAZARD LTD 32.5%

Value ($000) $7 Shares 206,800 Est. Cost $0.03 Unrealized —

— ICOSAVAX INC 13.6%

Value ($000) $3 Shares 190,654 Est. Cost $0.02 Unrealized —

— KARUNA THERAPEUTICS INC 11.6%

Value ($000) $3 Shares 8,130 Est. Cost $0.32 Unrealized —

LOGI LOGITECH INTL S A 0.6%

Value ($000) $0 Shares 1,363 Est. Cost $79.67 Unrealized 0.0%

FRO FRONTLINE PLC 0.6%

Value ($000) $0 Shares 6,412 Est. Cost $18.20 Unrealized 0.0%

RACE FERRARI N V 0.4%

Value ($000) $0 Shares 243 Est. Cost $333.89 Unrealized 0.0%

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
—	MIRATI THERAPEUTICS INC	153,920	$9	40.8%	$0.06	—	COM	60468T105
—	LAZARD LTD	206,800	$7	32.5%	$0.03	—	SHS A	G54050102
—	ICOSAVAX INC	190,654	$3	13.6%	$0.02	—	COM	45114M109
—	KARUNA THERAPEUTICS INC	8,130	$3	11.6%	$0.32	—	COM	48576A100
LOGI	LOGITECH INTL S A	1,363	$0	0.6%	$79.67	0.0%	SHS	H50430232
FRO	FRONTLINE PLC	6,412	$0	0.6%	$18.20	0.0%	COM	M46528101
RACE	FERRARI N V	243	$0	0.4%	$333.89	0.0%	COM	N3167Y103